A phase II study evaluating tipifarnib in mHRAS, recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) (AIM-HN study) Meeting Abstract
| Authors: | Ho, A. L.; Adkins, D. R.; Hanna, G. J.; Bruce, J.; Ahn, M. J.; Iglesias Docampo, L.; Kang, H.; Wong, D. J.; Psyrri, A.; Gillison, M.; BranĚa, I.; Liu, Y. C.; Hsieh, C. Y.; Hong, M. H.; Zhang, Z.; Balsara, B.; Saunders, A.; Gasco Hernandez, A.; Dale, S.; Haddad, R. |
| Abstract Title: | A phase II study evaluating tipifarnib in mHRAS, recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) (AIM-HN study) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1286 |
| End Page: | S1287 |
| Language: | English |
| ACCESSION: | WOS:001087480203527 |
| DOI: | 10.1016/j.annonc.2023.10.041 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA47 -- Source: Wos |
